SEC Form 4 · accession 0001630998-15-000002
Syneos Health, Inc. · SYNH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Gibertini
Officer — President Clinical Development
Period of report
May 7, 2015
Accepted (ET)
May 11, 2015 · 8:15 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610950
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1 | May 7, 2015 | S | 50,000 | $29.68 | D | 27,870 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price represents the public offering price of $31.00 per share of Common Stock, par value $0.01 per share (each, a "Share"), of INC Research Holdings, Inc., less the underwriting discount of $1.32 per Share.